NCT02032706

Brief Summary

The purpose of this study is to assess the accuracy of Night Shift in the detection of supine sleep and efficacy of vibro-tactile feedback in restricting supine sleep.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 10, 2014

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

March 2, 2016

Completed
Last Updated

April 1, 2016

Status Verified

June 1, 2014

Enrollment Period

8 months

First QC Date

January 8, 2014

Results QC Date

April 28, 2014

Last Update Submit

March 4, 2016

Conditions

Keywords

obstructive sleep apneaposition therapysnoringpositional

Outcome Measures

Primary Outcomes (2)

  • Percentage of Participants Who Completed the Study at 4 Weeks Without Adverse Events

    Assess the potential for adverse events by evaluating whether more than 20% of participants chose to terminate the study prior to completing 4 weeks of therapy.

    Four weeks

  • Evaluate Efficacy Based on a Change in Obstructive Sleep Apnea (OSA) Severity as a Result of Therapy

    Determine the percentage of participants that exhibited at least a 50% reduction in OSA severity measured by AHI after 4 weeks of therapy.

    30-days

Secondary Outcomes (8)

  • Confirmation That Night Shift Accurately Detects Supine Position

    baseline and 4-weeks later at follow up

  • Evaluate Whether Night Shift Disrupts Sleep Such That Users Are Non-compliant

    four weeks

  • Evaluate Whether Patients Adapt and Sleep Through the Position Therapy Feedback

    four weeks

  • Evaluate Efficacy by Confirming Position Therapy Reduces Daytime Somnolence in Patients With Positional OSA

    baseline and followup

  • Evaluate Impact of Positional Therapy on Quality of Life Scores

    four weeks

  • +3 more secondary outcomes

Study Arms (1)

Positional feedback

EXPERIMENTAL

Deliver therapy when the supine position is detected

Device: Deliver therapy when the supine position is detected

Interventions

Application of vibrotactile feedback to the neck when the supine position is detected

Also known as: Night Shift
Positional feedback

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be between the age of 18 and 75 years,
  • have been diagnosed with Obstructive Sleep Apnea (OSA) during polysomnography at a designated sleep center within 4 months of their enrollment,
  • have not received treatment with any OSA therapy for more than 3 days within the past month,
  • have an overall Apnea-Hypopnea Index (AHI) \> 10 and hypopneas requiring \>3% oxygen desaturation,
  • having a non-supine Apnea-Hypopnea Index (AHI) \< 15 if Continuous Positive Airway Pressure has not been attempted,
  • have a overall AHI divided by the non-supine AHI \> 1.5,
  • had an Epworth Sleepiness Score of 5 or more at the time of diagnosis and at the start of therapy,
  • Change in weight of no more than 5 pounds since the diagnostic PSG
  • access to a computer and the Internet
  • sleep is sometime between 8 P.M. to 9 A.M. Monday through Friday in the same bed

You may not qualify if:

  • Neck, back or should pain which would impact ability to sleep laterally each night
  • Body mass index \> 35
  • suffering from neurological disorders which result in ticks or tremors
  • diagnosed with congestive heart failure or chronic obstructive pulmonary disease
  • suffered from a stroke within the previous 12 months
  • taking or planning to take narcotic medications
  • unfamiliar with use of internet browsers
  • travel (i.e., foreign or cruise ship) which would limit internet or mail access
  • planned medical procedures (e.g., surgery) which would limit device use during the scheduled 30-day study period or introduce the need for narcotic pain medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Complete Sleep Solutions

Murrieta, California, 92563, United States

Location

Related Publications (2)

  • Levendowski DJ, Seagraves S, Popovic D, Westbrook PR. Assessment of a neck-based treatment and monitoring device for positional obstructive sleep apnea. J Clin Sleep Med. 2014 Aug 15;10(8):863-71. doi: 10.5664/jcsm.3956.

    PMID: 25126032BACKGROUND
  • Levendowski DJ, Veljkovic B, Seagraves S, Westbrook PR. Capability of a neck worn device to measure sleep/wake, airway position, and differentiate benign snoring from obstructive sleep apnea. J Clin Monit Comput. 2015 Feb;29(1):53-64. doi: 10.1007/s10877-014-9569-3. Epub 2014 Mar 6.

    PMID: 24599632BACKGROUND

Related Links

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSnoring

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesRespiratory SoundsSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Daniel Levendowski
Organization
Advanced Brain Monitoring, Inc.

Study Officials

  • Daniel J Levendowski, MBA

    Advanced Brain Monitoring, Inc.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2014

First Posted

January 10, 2014

Study Start

June 1, 2013

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

April 1, 2016

Results First Posted

March 2, 2016

Record last verified: 2014-06

Locations